Board on Population Health and Public Health Practice
The National Academies
Institute of Medicine
Committee on the Assessment of the U.S. Drug Safety System
Meeting One
AGENDA
PLEASE NOTE:
Online presentations from the Drug Safety meeting are subject to copyright protection. Permission from the speaker is required prior to any copying, reproducing, or rebroadcasting any portion of the speaker's presentations. Additional copyright and legal policies of The National Academies can be read here.
Internet Explorer is recommended for viewing the slides. Some presentations may not be accessible with Netscape Navigator. The presentations are available as PDF files which require Adobe Acrobat Reader. Click here to download Adobe Acrobat Reader for free.
Wednesday, June 8, 2005
Meeting Location:
Keck Center of the National Academies
Room 100
500 5th Street, NW
Washington, DC 20001
10:00 a.m. - 10:35 a.m.
Charge to the Committee
Steven Galson
Acting Director of the Center for Drug Evaluation and Research
Food and Drug Administration
Janet Woodcock
Deputy Commissioner of Operations
Food and Drug Administration
PowerPoint Slides
10:35 - 11:00 a.m.
Questions from the Committee
11:00 - 11:45 a.m.
Perspectives of Pharmaceutical Manufacturers and Payors
Amit Sachdev
Executive Vice President, Health
Biotechnology Industry Organization (BIO)
Christine Simmon
Vice President of Public Affairs and Development
Generic Pharmaceutical Association (GPhA)
J. Russell Teagarden
Vice President of Clinical Practices & Therapeutics
Medco Health Solutions, Inc. (on behalf of the Pharmaceutical Care Management Association)
Alan Goldhammer
Associate Vice President for Regulatory Affairs
Pharmaceutical Research and Manufacturers of America (PhRMA)
11:45 - 12:00 p.m.
Questions from the Committee
12:00 - 12:45 p.m.
Consumer/Patient and Professional Organizations' Perspectives
David Borenstein
Member, Board of Directors
American College of Rheumatology (ACR)
John A. Gans
Executive Vice-President and Chief Executive Officer
American Pharmacists Association (APhA)
Bill Vaughan
Senior Policy Analyst
Consumers Union
Jeanne Ireland
Director of Public Policy
Elizabeth Glaser Pediatric AIDS Foundation
PowerPoint Slides
12:45 - 1:00 p.m.
Questions from the Committee
1:00 p.m.
Adjourn
|